Effect of Montelukast Therapy on Clinical Course, Pulmonary Function, and Mortality in Patients With COVID-19

NCT05094596 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

180

Enrollment

OTHER

Sponsor class

Conditions

COVID-19 Pneumonia

Interventions

DRUG: Standart treatment group
DRUG: Montelukast sodium 10 mg treatment
DRUG: Montelukast sodium 20 mg treatment

Sponsor

Bugra Kerget